76 related articles for article (PubMed ID: 10787016)
1. The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus.
Sekigawa I; Lee S; Kaneko H; Iida N; Hashimoto H; Hirose S; Kaneko Y
Lupus; 2000; 9(2):155-6. PubMed ID: 10787016
[No Abstract] [Full Text] [Related]
2. A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE.
Sekigawa I; Matsushita M; Lee S; Maeda N; Ogasawara H; Kaneko H; Iida N; Hashimoto H
Autoimmunity; 2000; 33(1):37-44. PubMed ID: 11204252
[TBL] [Abstract][Full Text] [Related]
3. [Possible pathogenic role of IL-16 on SLE: with reference to HIV-1 infection].
Lee S; Sekigawa I
Ryumachi; 1998 Oct; 38(5):747-51. PubMed ID: 9852753
[No Abstract] [Full Text] [Related]
4. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
5. Suppression of systemic lupus erythematosus by the human immunodeficiency virus.
Byrd VM; Sergent JS
J Rheumatol; 1996 Jul; 23(7):1295-6. PubMed ID: 8823711
[TBL] [Abstract][Full Text] [Related]
6. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
7. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cárdenas RV; Aliaga-Zamudio M; Zevallos F; Tineo-Pozo G; Cucho-Venegas JM; Mosqueira-Riveros A; Medina M; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
Lupus; 2016 Mar; 25(3):233-40. PubMed ID: 26385221
[TBL] [Abstract][Full Text] [Related]
8. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
Montes de Oca Arjona M; Pérez Cano R; Orozco MJ; Martín Aspas A; Guerrero F; Fernández Gutiérrez Del Alamo C; Girón-González JA
Clin Microbiol Infect; 2005 Jan; 11(1):57-62. PubMed ID: 15649305
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of human immunodeficiency virus infection and systemic lupus erythematosus.
Molina JF; Citera G; Rosler D; Cuéllar ML; Molina J; Felipe O; Espinoza LR
J Rheumatol; 1995 Feb; 22(2):347-50. PubMed ID: 7738963
[TBL] [Abstract][Full Text] [Related]
11. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
12. Lessons from similarities between SLE and HIV infection.
Sekigawa I; Okada M; Ogasawara H; Naito T; Kaneko H; Hishikawa T; Iida N; Hashimoto H
J Infect; 2002 Feb; 44(2):67-72. PubMed ID: 12076063
[TBL] [Abstract][Full Text] [Related]
13. CD8+CD28-, suppressive T cells in systemic lupus erythematosus.
Tulunay A; Yavuz S; Direskeneli H; Eksioglu-Demiralp E
Lupus; 2008 Jul; 17(7):630-7. PubMed ID: 18625635
[TBL] [Abstract][Full Text] [Related]
14. CD8 lymphocytes in HIV infection: helpful and harmful.
Famularo G; Moretti S; Marcellini S; Nucera E; De Simone C
J Clin Lab Immunol; 1997; 49(1):15-32. PubMed ID: 9819670
[TBL] [Abstract][Full Text] [Related]
15. Lupus anticoagulant and HIV infection: a prospective study.
Boue F; Dreyfus M; Bridey F; Delfraissy JF; Dormont J; Tchernia G
AIDS; 1990 May; 4(5):467-8. PubMed ID: 2115343
[No Abstract] [Full Text] [Related]
16. Systemic lupus erythematosus patient with false positive results of antibody to HIV: A case report and a comprehensive literature review.
Jian L; Liang W; Zhang Y; Li L; Mei Y; Tan R; Sun L
Technol Health Care; 2015; 23 Suppl 1():S99-S103. PubMed ID: 26410337
[TBL] [Abstract][Full Text] [Related]
17. CD45 isoforms expression on CD4+ and CD8+ peripheral blood T-lymphocytes is related to auto-immune processes and hematological manifestations in systemic lupus erythematosus.
Neidhart M; Pataki F; Michel BA; Fehr K
Schweiz Med Wochenschr; 1996 Nov; 126(45):1922-5. PubMed ID: 8946597
[TBL] [Abstract][Full Text] [Related]
18. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.
Honda M; Mengesha E; Albano S; Nichols WS; Wallace DJ; Metzger A; Klinenberg JR; Linker-Israeli M
Clin Immunol; 2001 May; 99(2):211-221. PubMed ID: 11318593
[TBL] [Abstract][Full Text] [Related]
19. Bullous systemic lupus erythematosus in a patient with human immunodeficiency virus infection: a paradox of autoimmunity and immunodeficiency.
Maley A; Parker S
Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244171
[TBL] [Abstract][Full Text] [Related]
20. Differences between CD8+ T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model.
Karpouzas GA; La Cava A; Ebling FM; Singh RR; Hahn BH
Eur J Immunol; 2004 Sep; 34(9):2489-99. PubMed ID: 15307181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
